A 65-year-old female with Stage III breast cancer [ER+/PR+, HER2neu (-)] is to proceed with adjuvant chemotherapy followed by an aromatase inhibitor for 5 years. Her history is significant for hypertension and dyslipidemia. Her serum 25(OH) vitamin D level is 19.1ng/ml. Physical activity and a Fracture Risk Assessment (FRAX) were both recommended.

Which management strategy should be recommended for this patient’s bone health?

Click NEXT to view the answer and an explanation.

Continue Reading